Covered recipient · General Payments record
MICHAEL JOSEPH PARKER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2023
$1,078.46
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $323.57 | 15 |
| Education | $62.99 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $92.19 | 3 |
| Alkermes, Inc. | $79.57 | 3 |
| ITI, Inc. | $57.07 | 3 |
| Teva Pharmaceuticals USA, Inc. | $48.66 | 2 |
| Indivior Inc. | $24.85 | 1 |
| Neurocrine BioSciences, Inc. | $22.23 | 1 |
| ABBVIE INC. | $21.98 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.12 | 1 |
| Lundbeck LLC | $19.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.98 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009095169 | CMS |
| Alkermes, Inc. | $27.26 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022891495 | CMS |
| Alkermes, Inc. | $24.71 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022891497 | CMS |
| Alkermes, Inc. | $27.60 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022891499 | CMS |
| Indivior Inc. | $24.85 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034371191 | CMS |
| ITI, Inc. | $18.50 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1041069703 | CMS |
| ITI, Inc. | $17.44 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1041069709 | CMS |
| ITI, Inc. | $21.13 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1041069717 | CMS |
| Janssen Pharmaceuticals, Inc | $15.25 | 01/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988612655 | CMS |
| Janssen Pharmaceuticals, Inc | $13.95 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988612653 | CMS |
| Janssen Pharmaceuticals, Inc | $62.99 | 02/23/2023 | Education | Undisputed | 01/23/2026 | 988612651 | CMS |
| Lundbeck LLC | $19.89 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032646943 | CMS |
| Neurocrine Biosciences, Inc. | $22.23 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052122149 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.12 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015482709 | CMS |
| Teva Pharmaceuticals USA, Inc. | $24.81 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056849343 | CMS |
| Teva Pharmaceuticals USA, Inc. | $23.85 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056849345 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.